NCT06678243 Testing the mHealth App Intervention for Nondaily Smokers "SiS4"
| NCT ID | NCT06678243 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Massachusetts General Hospital |
| Condition | Smoking Cessation |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,600 participants |
| Start Date | 2024-12-06 |
| Primary Completion | 2027-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,600 participants in total. It began in 2024-12-06 with a primary completion date of 2027-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this project is to test if a new behavioral treatment for people who smoke nondaily and wish to quit works. The new treatment is a smartphone app that engages users in positive psychology exercises and gives them tested tools for quitting smoking. The positive psychology exercises help users maintain their positive emotions while they quit smoking. This app has been developed with and for people who smoke nondaily through several steps of development. The main questions it aims to answer are: * Does the smoking cessation app (SiS4) help people who smoke nondaily quit smoking? * How do people's attitudes towards smoking, their smoking urges, and their mental well-being shift when using the SiS4 app? Researchers will compare the new app to an existing app that was developed for people who smoke daily to see if the new app works better to help people who smoke nondaily quit smoking. Participants will: 1. Use a smartphone app every day for 7 weeks 2. Complete online surveys about their smoking, attitudes about smoking, withdrawal symptoms and smoking urges, app use, and mental well-being at enrollment as well as 2 weeks, 6 weeks, 3 months, 6 months and 12 months after the initially chosen quit date. If the SiS4 app works well, it would be the first evidence-based quit-smoking treatment for people who smoke nondaily.
Eligibility Criteria
* 18 years of age or older * Sufficiently fluent in English to read and comprehend intervention and assessment materials * Owns a smartphone (Android or iOS only) * Currently smokes less than daily but at least weekly * Has smoked 100+ cigarettes lifetime * Has current intention to quit smoking * Currently resides in the US * Can use online survey technology to complete surveys * Can download, install and use a smartphone app
Contact & Investigator
Bettina Hoeppner, Ph.D., M.S.
PRINCIPAL INVESTIGATOR
Massachusetts General Hospital
Frequently Asked Questions
Who can join the NCT06678243 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Smoking Cessation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06678243 currently recruiting?
Yes, NCT06678243 is actively recruiting participants. Contact the research team at bhoeppner@mgh.harvard.edu for enrollment information.
Where is the NCT06678243 trial being conducted?
This trial is being conducted at Boston, United States.
Who is sponsoring the NCT06678243 clinical trial?
NCT06678243 is sponsored by Massachusetts General Hospital. The principal investigator is Bettina Hoeppner, Ph.D., M.S. at Massachusetts General Hospital. The trial plans to enroll 1,600 participants.